Caesarstone Ltd CSTE Q1 2026 Earnings Narrower Loss Surprises Shares Rally on Improved Margin Outlook Tempest Therapeutics Inc TPST Q1 2026 Earnings Significant EPS Miss with No Revenue Stock Edges Up Xenon Pharmaceuticals XENE Q1 2026 Earnings Narrowerthanexpected loss highlights operational progress RenaissanceRe Holdings Ltd RNR Q1 2026 Earnings Strong Underwriting Drives EPS Beat of 23 Mineralys Therapeutics MLYS Q1 2026 Earnings Narrowerthanexpected Loss as Clinical Progress Continues